Regulation of dopamine and MPP + transport by catecholamine transporters

Japanese Journal of Neuropsychopharmacology

Volumn 24, Issue 2, 2004, Pages 43-47

  Uhl, George R ^a   Dohi, Toshihiro ^b   Kitayama, Shigeo ^c   Morioka, Norimitsu ^b   Kumagai, Kei ^b   Mitsuhata, Chieko ^b   Morita, Katsuya ^b   Kozai, Katsuyuki ^b   Lin, Zhicheng ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b HIROSHIMA UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

Cocaine; Dopamine transporter; MPP +; Nicotine; Norepinephrine transporter

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; AMPHETAMINE; BIOGENIC AMINE; CATECHOLAMINE; COCAINE; COMPLEMENTARY DNA; DOPAMINE; DOPAMINE TRANSPORTER; NEUROTOXIN; NEUROTRANSMITTER; NICOTINE; NORADRENALIN TRANSPORTER; PROTEIN KINASE C; PSYCHOTROPIC AGENT;

AMINO ACID SUBSTITUTION; ATTENTION DEFICIT DISORDER; CATECHOLAMINE RELEASE; DEPRESSION; DRUG DEPENDENCE; DRUG MECHANISM; DRUG TARGETING; EXOCYTOSIS; NONHUMAN; PARKINSONISM; PROTEIN PROTEIN INTERACTION; REVIEW; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRUCTURE ANALYSIS; SYNAPTIC MEMBRANE; VARIABLE NUMBER OF TANDEM REPEAT;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CATECHOLAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; COCAINE; DOPAMINE; DRUG DESIGN; HUMANS; MEMBRANE TRANSPORT PROTEINS; NICOTINE;

EID: 2442653808     PISSN: 13402544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Dougherty, D. D., Bonab, A. A., Spencer, T. J., Rouch, S. L., Madras, B. K. and Fischman, A. J. (1999) Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet, 354: 2132-2133.
2. Drew, A. E. and Werling, L. L. (2001) Protein kinase C regulation of dopamine transporter initiated by nicotinic receptor activation in slices of rat prefrontal cortex. J Neurochem, 77: 839-848.
3. Drew, A. E. Derbez, A. E. and Werling, L. L. (2000) Nicotinic receptor-mediated regulation of dopamine transporter activity in rat prefrontal cortex. Synapse, 38: 10-16.
4. Huang, C.-L., Chen, H.-C., Huang N.-K., Yang, D.-M., Kao, L.-S., Chen, J.-C., Lai, H.-L. and Chem, Y. (1999) Modulation of dopamine transporter activity by nicotinic acetylcholine receptors and membrane depolarization in rat pheochromocytoma PC12 cells. J Neurochem, 72: 2437-2444.
5. Kitayama, S., Shimada, S., Xu, H., Markham, L., Donovan, D. M. and Uhl, G. R. (1992) Dopamine transporter site-directed mutations differentially alter sunstrate transport and cocaine binding. Proc Natl Acad Sci USA, 89: 7782-7785.
6. + transport. Synapse, 15: 58-62.
7. Kitayama, S., Dohi, T. and Uhl, G. R. (1994) Phorbol esters alter functions of the expressed dopamine transporter. Eur J Pharmacol, 268: 115-119.
8. - but not dopamine through the rat dopamine transporter. Eur J Pharmacol, 309: 107-109.
9. Kitayama, S., Morita, K., Dohi, T., Wang, J.-B., Davis, S. C., and Uhl, G. R. (1996b) Dissection of dopamine and cocaine binding sites on the rat dopamine transporter expressed in COS cells. Annal NY Acad Sci, 801: 388-393.
10. + toxicity and plasma membrane dopamine transporter: Study using cell lines expressing the wild-type and mutant rat dopamine transporters. Biochim Biophys Acta, 1404: 305-313
11. Krause, K.-H., Dresel, S. H. Krause, J., Kung, H. K. and Tatsch, K. (2000) Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: Effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett, 285: 107-110.
12. Krause, K.-H., Dresel, S. H. Krause, J., Kung, H. K., Tatsch, K. and Ackenheil, M. (2002) Stimulant-like action of nicotine on striatal dopamine transporter in the brain of adults with attention deficit hyperactivity disorder. Int J Neuropsychopharmacol, 5: 111-113.
13. Miller, G. M. and Madras, B. K. (2002) Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol Psychiatry, 7: 44-55.
14. Mitsuhata, C., Kitayama, S., Morita, K., Vandenbergh, D., Uhl, G. R. and Dohi, T. (1998) Tyrosine-533 of rat dopamine transporter: Involvement in interactions with 1-methyl-4-phenylpyridinium and cocaine. Mol Brain Res, 56: 84-88.
15. Morens, D. M., Grandinetti, A., Reed, D., White, L. R. and Ross, G. W. (1995) Cigarette smoking and protection from Parkinson's disease: False association or etiologic clue? Neurology, 45: 1041-1051.
16. Nisell, M., Nomikos, G. G., Hertel, P., Panagis, G. and Sevensson, T. H. (1996) Condition-induced sensitization of locomotor stimulant and mesocortical dopamine release following chronic nicotine treatment in the rat. Synapse, 22: 369-381.
17. + levels in mice. Brain Res, 917: 219-224.
18. Quik, M. and Kulak, J. M. (2002) Nicotine and nicotinic receptors; Relevance to Parkinson's disease. NeuroToxicol, 23: 581-594.
19. Yamashita, H., Kitayama, S., Zhang, Y.-X., Takahashi, T., Dohi, T. and Nakamura, S. (1995) Effect of nicotine on dopamine uptake in COS cells possessing the rat dopamine transporter and in PC12 cells. Biochem Pharmacol, 49: 742-745.